THC Tenet Healthcare Corporation New

XNYS 269.94 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

THC $269.94 —
Key stats
$269.94
52-Week Range
$157.58 – $283.05
YTD
+35.34%
IV Rank (30D)
68.52
Straddle Price
$30.75
P/C Vol Ratio
0.31
Market Cap
$21.7B
Open
$268.69
Day Range
$266.53 – $270.39
Volume
17,798
Prev Close
$270.63
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY1.10
Cost of Equity (CAPM)11.20% (VRP-adj)
WACC9.18%
Volatility Risk Premium+70.0pp (IV − HV30), ERP adj +50bps
Effective Tax Rate17.9%
Rev. Growth (YoY, DCF input)+5.1%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.05 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$3.0B
Return on Equity (TTM)48.1%
Book / Price27.6%
Gross Margin (TTM)100.0%
FCF Margin (TTM)13.7%
Debt / Equity2.00
Quality Score3/6 — normal (10y DCF)
Market-Implied Growth-2.4% (reverse-DCF on current price)
SMA 50$264.85 (Market Anchor value)
SMA 20 / Bollinger Mid$263.68
Bollinger Width / SMA203.5% (drives anchor stability)
Net Debt$10.9B
Market Cap$24B
Peers used for multiples: CI, CNC, ELV, EXEL, HCA, UHS, UNH, UTHR
60-Day Conviction
84%
20-Day Fair Value
≈ by Nov 23, 2026
$276.36
α +2.3% rank 72%
conviction
94%
40-Day Fair Value
≈ by Dec 22, 2026
$280.23
α +3.8% rank 71%
conviction
93%
60-Day Fair Value
≈ by Jan 20, 2027
$278.59
α +3.2% rank 74%
conviction
84%
MethodImplied PriceWeightDetail
DCF $492.58 19%
DDM (Gordon) n/a 0%
Peer P/E $499.25 9% median 18.3× · 7 peers
Peer EV/EBITDA $503.78 9% median 10.9× · 8 peers
Peer P/B $157.67 2% median 2.1× · 7 peers
Peer P/S $188.07 6% median 0.7× · 8 peers
Market Anchor (SMA50) $264.85 38% stability 100% (BB-width)
Options Expected (B-L 30d) $273.43 19% 44 strikes · skew +0.17
As of 2026-10-23 · updated
About
Industry (SIC)
SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC (8062) · industry map
Exchange
XNYS
Market Cap
$21.7B
Employees
99,000
List Date
1972-06-01
CIK
0000070318
Next Earnings
2026-10-29 (Pre-Market)
EPS Forecast
$4.60 (7 est.)
Headquarters
Dallas, TX
Homepage
https://www.tenethealth.com

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan21.27%-7.29%11.98%8.83%12.51%-5.10%7.03%
Feb0.59%15.21%3.12%4.37%-12.48%27.31%6.35%
Mar-1.66%-2.44%-0.22%11.48%7.98%-19.74%-0.77%
Apr15.76%-16.41%25.46%7.57%7.16%-6.91%5.44%
May7.40%-9.81%-1.49%16.62%16.16%-4.34%4.09%
Jun-2.22%-16.72%12.17%-0.49%3.46%9.99%1.03%
Jul5.77%20.22%-8.14%12.30%-9.10%33.04%9.01%
Aug5.81%-13.92%1.02%12.09%16.60%6.37%4.66%
Sep-11.40%-8.50%-16.28%2.81%9.54%-3.87%-4.62%
Oct4.13%-17.32%-18.85%-4.82%2.56%6.34%*-4.66%
Nov1.93%1.16%29.99%-8.61%7.67%--6.43%
Dec15.84%7.59%6.42%-11.12%-7.63%--2.22%
Total77.79%-44.25%39.31%58.15%62.16%37.40%38.43%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $264.20
SMA 50: $264.91
SMA 200: $218.49
Current: $270.06
EMA 12: $268.00
EMA 26: $265.06
MACD: 2.9408 | Signal: 0.5306
BULLISH
ADX (14): 11.83
RANGE
+DI: 19.58
−DI: 17.29

Momentum Oscillators

RSI (14): 56.35
NEUTRAL
Stoch %K: 62.37
Stoch %D: 64.53
Williams %R: -37.97

Volume & Volatility

BB Upper: $276.55
BB Lower: $251.84
NEUTRAL
OBV: 39,105,597
Vol SMA 20: 526,860
Vol ROC: -96.66%
ATR: $7.06
True Range: $4.10
HV 20: 19.9%
HV 30: 24.1%
HV 60: 26.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-24T00:00:00 – 2026-10-22T00:00:00
AI Analysis

TENET HEALTHCARE (THC) - COMPREHENSIVE STOCK ANALYSIS REPORT

EXECUTIVE SUMMARY

Overall Assessment: NEUTRAL | Confidence Level: 6/10

Tenet Healthcare presents a mixed technical and fundamental picture with conflicting signals that warrant cautious observation rather than directional conviction. The stock is trading in a consolidation range with weak momentum despite positive recent news sentiment. While the company demonstrates defensive characteristics (low beta of 0.50), the breakdown in volume (-82.73% rate of change) and bearish options positioning suggest institutional caution. The technical setup lacks clear directional bias, positioning THC as a "watch and wait" situation until stronger momentum emerges or key catalysts materialize.

Key Drivers:

  • Positive analyst sentiment and growth narrative (Wall Street bullish)
  • Strong capital-return strategy supporting shareholder value
  • Defensive risk profile (low volatility, low beta) provides downside cushion

Primary Risks:

  • Significant volume deterioration suggesting waning institutional interest
  • Bearish options positioning (1.59x put/call volume ratio, 1.73x OI ratio)
  • Weak trend strength (ADX 15.42 = range-bound market)
  • Negative insider activity (director share sale on 09-20)

Investment Thesis: Tenet Healthcare is a defensive healthcare play with solid fundamental support from Wall Street analysts and improving capital allocation, but near-term technical weakness and collapsing volume suggest institutional money is rotating away. The stock lacks the momentum to challenge resistance, making current levels a consolidation zone rather than a breakout opportunity.

Recent News Sentiment Impact: Moderately Positive (3 positive vs 3 neutral headlines). News supports the fundamental case but has failed to drive technical breakout, suggesting sentiment may already be priced in or lacks conviction among institutional traders.

TECHNICAL ANALYSIS

Trend Direction

| Timeframe | Direction | Strength | Status | |-----------|-----------|----------|--------| | Short-term (1-4 weeks) | RANGE-BOUND | Weak | Price oscillating between $251-$269 | | Medium-term (1-3 months) | NEUTRAL/SLIGHTLY BULLISH | Weak | Consolidating above 200-SMA ($213.48) | | Long-term (3-12 months) | BULLISH | Moderate | Trading +21.2% above 200-day MA |

Trend Assessment: The stock exhibits textbook range-bound behavior. Price ($258.62) is slightly below the 20-SMA ($260.39) and 50-SMA ($261.73), indicating recent weakness, but remains comfortably above the 200-SMA ($213.48), confirming the longer-term uptrend is intact. However, the proximity to short-term moving averages without clear directional conviction suggests consolidation rather than breakout.

Support/Resistance Levels

| Level | Type | Confluence | Significance | |-------|------|-----------|--------------| | $251.57 | SUPPORT | Bollinger Bands Lower, -1 ATR from price | Primary support; break below initiates breakdown scenario | | $258.62 | CURRENT PRICE | -- | Trading at neutral zone | | $260.39 | RESISTANCE | 20-SMA, BB Middle | Immediate resistance; necessary to reclaim uptrend | | $269.21 | RESISTANCE | Bollinger Bands Upper, recent range top | Secondary resistance; breakout level | | $276-$280 | STRUCTURAL RESISTANCE | 52-week range extension | Major resistance zone if $269 breaks | | $213.48 | MAJOR SUPPORT | 200-SMA | Absolute floor; no technical breakdown risk above this |

Momentum Signals

RSI (14): 49.80 — NEUTRAL

  • Reading sits precisely at the midpoint (neutral zone 30-70), indicating no overbought or oversold condition
  • Neither buying nor selling pressure from momentum perspective
  • Suggests market has priced in current information; room for movement in either direction
  • Signal: No momentum edge; RSI offers no confirmation for breakout

MACD: -0.77 / Signal: -1.06 / Histogram: +0.28 — EARLY BULLISH SIGNAL (WEAK)

  • MACD line (-0.77) is above signal line (-1.06), creating positive histogram (+0.28)
  • This represents an early bullish crossover or bounce from oversold MACD levels
  • However, both MACD and signal line remain negative (below zero), indicating the dominant trend in the MACD is still bearish
  • Interpretation: Not a strong bullish signal; rather, a reversal from bearish momentum rather than establishment of new bullish momentum
  • Signal: Potential momentum inflection point, but needs confirmation via price action and histogram expansion

Stochastic Oscillators: %K 35.60 / %D 35.04 — NEUTRAL/MILDLY BEARISH

  • Both values in lower-middle range (below 50), suggesting slightly more selling pressure
  • No overbought signal (>80) or oversold signal (<20)
  • %K and %D nearly equal, indicating momentum is stabilizing but not reversing strongly
  • Signal: Lack of urgency from momentum; stock is "stuck"

Williams %R: -48.41 — NEUTRAL

  • Reading near midpoint of -100 to 0 range, confirming lack of directional momentum
  • Not near extreme readings that would suggest imminent reversal

Bollinger Bands Analysis

| Metric | Value | Interpretation | |--------|-------|-----------------| | Width | 6.77 (tight) | Band squeeze; low volatility environment | | Position | Price near middle (BB Middle: $260.39) | Neutral zone; no overbought/oversold pressure | | Upper Band | $269.21 | +$10.59 from current (4.1% upside) | | Lower Band | $251.57 | -$7.05 from current (2.7% downside) |

Bands Signal: The tight width (6.77) combined with price near the middle band indicates low volatility regime with consolidation. This is a classic "squeeze" setup—when bands tighten significantly, a breakout (in either direction) typically follows. However, no directional bias is evident yet. An expansion beyond $269.21 or below $251.57 would be the trigger.

Volume Analysis

Critical Finding: Severe Volume Deterioration

| Metric | Value | Interpretation | |--------|-------|-----------------| | Volume Rate of Change | -82.73% | SEVERE DECLINE | | Volume SMA 20 | 746,002 shares | Baseline daily volume | | On-Balance Volume | 29,519,674 | Cumulative volume trend (positive) |

Volume Assessment: The -82.73% volume rate of change is a major red flag. This indicates that recent trading volume is approximately 17% of the 20-day average—an 83% collapse in participation. This severe deterioration suggests:

  1. Institutional Disengagement: Large traders have reduced positions or are taking a "wait and see" approach
  2. Lack of Conviction: Both buyers and sellers are sitting on sidelines; no conviction to move price
  3. Breakout Risk: Low volume makes any eventual breakout vulnerable to sudden reversal or whipsaw (false break)
  4. Liquidity Concern: Thinning liquidity could magnify moves in either direction once volume returns

Despite the positive OBV trend (accumulation), the recent volume collapse undermines the reliability of a bullish breakout. This is a key conflict: news is positive, but money is leaving.

NEWS & SENTIMENT ANALYSIS

Recent Headlines Summary (10 Most Recent Articles)

| Date | Headline | Sentiment | Key Theme | |------|----------|-----------|-----------| | 2026-10-02 | Outpaces Stock Market Gains | NEUTRAL | Performance statement, no catalyst | | 2026-09-30 | Cash Flow Support Expanding Capital-Return | POSITIVE | Shareholder returns, financial strength | | 2026-09-30 | Strong Growth Stock | POSITIVE | Growth narrative, analyst support | | 2026-09-22 | Pediatrix Growth Despite Patient Volumes | POSITIVE | Subsidiary resilience | | 2026-09-20 | Director Sells 1,152 Shares | NEUTRAL | Insider activity (mildly bearish interpretation) | | 2026-09

Generated
News
All THC news →
Earnings History
18 of 23 under expected move
Avg Expected Move
9.24%
Avg Actual Move
6.08%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-01-11 Pre-Market 6.41% 1.22% 0.19x Within
2021-04-20 Pre-Market 5.80% 1.01% 0.17x Within
2021-07-21 Pre-Market 6.10% 2.45% 0.40x Within
2021-10-20 Pre-Market 12.10% 1.86% 0.15x Within
2022-01-11 Pre-Market 6.84% 4.02% 0.59x Within
2022-04-20 Pre-Market 10.55% 5.55% 0.53x Within
2022-07-21 Pre-Market 9.72% 1.71% 0.18x Within
2022-10-20 Pre-Market 8.35% 0.26% 0.03x Within
2023-01-19 Pre-Market 3.56% 3.11% 0.87x Within
2023-04-25 Pre-Market 7.46% 2.67% 0.36x Within
2023-07-31 Pre-Market 8.67% 0.50% 0.06x Within
2023-10-30 Pre-Market 12.20% 0.24% 0.02x Within
2024-02-01 Pre-Market 9.91% 7.70% 0.78x Within
2024-04-30 Pre-Market 7.61% 13.25% 1.74x Exceeded
2024-07-24 Pre-Market 9.09% 4.80% 0.53x Within
2024-10-29 Pre-Market 10.65% 16.68% 1.57x Exceeded
2025-02-12 Pre-Market 10.34% 9.10% 0.88x Within
2025-04-29 Pre-Market 12.07% 11.65% 0.97x Within
2025-07-22 Pre-Market 10.59% 10.70% 1.01x Exceeded
2025-10-28 Pre-Market 10.22% 5.34% 0.52x Within
2026-02-11 Pre-Market 8.73% 17.26% 1.98x Exceeded
2026-04-30 Pre-Market 12.35% 1.65% 0.13x Within
2026-07-24 Pre-Market 13.16% 17.17% 1.30x Exceeded

Earnings calendar: this week’s reports with expected vs actual moves →

THC Options Activity & IV Rank

THC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 50.7%
7-DTE IV: —
Expected Move: $30.75
7-DTE Move: $30.75
Days to Exp: 28 (2026-11-20)

Options Flow

Call Volume: 231
Put Volume: 72
P/C Volume: 0.312
BULLISH
Call OI: 2,247
Put OI: 1,883
P/C OI: 0.838
Total OI: 4,130

ATM Options Pricing

ATM Call: $15.40
ATM Put: $15.35
Call %: 5.7%
Put %: 5.7%

Chain Summary

Chain Volume: 2,284
Chain OI: 15,669
Last Updated: 10/23/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 29th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
29%
vs own history
GEX tilt
+0.02
OI-weighted, today
Vanna tilt
+0.69
δ-sensitivity to IV
Charm tilt
-0.67
δ-decay vs time
Vanna tilt +0.69: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.67: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 48 ATM contracts, 7k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d 48%
+7.0 pts EXTREME
ATM 52.0% / Wing 59.1%

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)68.5MediumOct 23
Straddle Price (30 DTE)$30.75Oct 23
Beta Analysis

Risk Metrics

Beta: 0.4887
Alpha: 29.27%
Correlation: 0.1438
R-Squared: 2.1%
Stock Volatility: 43.3%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own THC
6 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Glenview Capital Hedge fund
Larry Robbins
$418.2M
8.35%
#3 of 42+46.6%13F
Citadel Hedge fund
Ken Griffin
$330.3M
0.19%
#91 of 6285+321.6%13F
Millennium Management Hedge fund
Izzy Englander
$86.3M
0.06%
#389 of 3716+26.5%13F
Point72 Hedge fund
Steve Cohen
$35.0M
0.05%
#427 of 1945new13F
Bridgewater Associates Hedge fund
Ray Dalio
$7.9M
0.03%
#377 of 997+125.9%13F
Rockefeller Capital Management Family office
Rockefeller family
$2.2M
0.00%
#1342 of 4729-0.2%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

THC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 87,750,750 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

723 filers89,608,824 shares$17.43B value102.12% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 8,856,018 $1.76B 10.10% 10.09% 2025-12-31
2 BlackRock, Inc. Custodian 8,743,005 $1.64B 9.39% 9.96% 2026-06-30
3 T. Rowe Price Associates, Inc. 7,957,449 $1.49B 8.54% 9.07% 2026-06-30
4 Boston Partners 4,433,360 $829.06M 4.76% 5.05% 2026-06-30
5 Vanguard Portfolio Management LLC 4,238,108 $792.87M 4.55% 4.83% 2026-06-30
6 FMR LLC Custodian 3,994,545 $747.30M 4.29% 4.55% 2026-06-30
7 Vanguard Capital Management LLC 3,894,189 $728.52M 4.18% 4.44% 2026-06-30
8 PeakShares LLC 2,753 $515.03M 2.96% <0.01% 2026-06-30
9 State Street Corp 2,751,290 $514.71M 2.95% 3.14% 2026-06-30
10 GLENVIEW CAPITAL MANAGEMENT, LLC 2,235,666 $418.25M 2.40% 2.55% 2026-06-30
11 Geode Capital Management, LLC Custodian 1,884,982 $352.72M 2.02% 2.15% 2026-06-30
12 Citadel Advisors LLC Custodian 1,765,596 $330.31M 1.90% 2.01% 2026-06-30
13 Arrowstreet Capital, Limited Partnership 1,708,453 $319.62M 1.83% 1.95% 2026-06-30
14 Ameriprise Financial, Inc. Custodian 1,664,068 $311.46M 1.79% 1.90% 2026-06-30
15 Dimensional Fund Advisors LP Custodian 1,450,408 $271.35M 1.56% 1.65% 2026-06-30
16 Invesco Ltd. Custodian 1,416,948 $265.08M 1.52% 1.61% 2026-06-30
17 Victory Capital Management Inc. 1,237,915 $231.59M 1.33% 1.41% 2026-06-30
18 Norges Bank 1,214,240 $227.16M 1.30% 1.38% 2026-06-30
19 AQR Capital Management, LLC Custodian 1,067,556 $198.27M 1.14% 1.22% 2026-06-30
20 AllianceBernstein L.P. 910,270 $171.78M 0.99% 1.04% 2026-06-30
21 MANNING & NAPIER ADVISORS LLC 901,645 $168.76M 0.97% 1.03% 2026-06-30
22 Bank of America Corp Custodian 854,858 $159.93M 0.92% 0.97% 2026-06-30
23 Morgan Stanley Custodian 831,612 $155.58M 0.89% 0.95% 2026-06-30
24 T. Rowe Price Investment Management, Inc. 793,887 $148.52M 0.85% 0.90% 2026-06-30
25 Northern Trust Corp Custodian 781,265 $146.16M 0.84% 0.89% 2026-06-30
17 filers$177.70M notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $36.48M 20.53% 2026-06-30
2 Susquehanna International Group, LLP Custodian $33.45M 18.82% 2026-06-30
3 Citadel Advisors LLC Custodian $24.19M 13.61% 2026-06-30
4 TUDOR INVESTMENT CORP ET AL $16.63M 9.36% 2026-06-30
5 NOMURA HOLDINGS INC $16.18M 9.11% 2026-06-30
6 Wolverine Trading, LLC Custodian $12.64M 7.11% 2025-09-30
7 UBS Group AG Custodian $10.42M 5.86% 2026-06-30
8 Walleye Trading LLC $10.18M 5.73% 2026-06-30
9 Cubist Systematic Strategies, LLC $9.83M 5.53% 2025-09-30
10 Verition Fund Management LLC $2.86M 1.61% 2026-06-30
11 Goldman Sachs Group Inc Custodian $1.31M 0.74% 2026-06-30
12 Squarepoint Ops LLC $1.25M 0.71% 2026-06-30
13 Millennium Management LLC Custodian $916.69K 0.52% 2026-06-30
14 Walleye Capital LLC $785.74K 0.44% 2026-06-30
15 Balyasny Asset Management L.P. $261.91K 0.15% 2026-06-30
16 Point72 Asset Management, L.P. $187.08K 0.11% 2026-06-30
17 Qube Research & Technologies Ltd $130.96K 0.07% 2026-06-30
21 filers$238.56M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $45.54M 19.09% 2026-06-30
2 Citadel Advisors LLC Custodian $39.79M 16.68% 2026-06-30
3 Jane Street Group, LLC Custodian $31.84M 13.35% 2026-06-30
4 Pentwater Capital Management LP $22.45M 9.41% 2026-06-30
5 TUDOR INVESTMENT CORP ET AL $16.29M 6.83% 2026-06-30
6 NOMURA HOLDINGS INC $16.18M 6.78% 2026-06-30
7 Wolverine Trading, LLC Custodian $16.08M 6.74% 2025-09-30
8 Walleye Trading LLC $12.20M 5.11% 2026-06-30
9 UBS Group AG Custodian $12.20M 5.11% 2026-06-30
10 Cubist Systematic Strategies, LLC $7.19M 3.01% 2025-09-30
11 WOLVERINE ASSET MANAGEMENT LLC $6.92M 2.90% 2026-06-30
12 Goldman Sachs Group Inc Custodian $3.22M 1.35% 2026-06-30
13 BRANT POINT INVESTMENT MANAGEMENT LLC $2.81M 1.18% 2026-06-30
14 Millennium Management LLC Custodian $2.04M 0.85% 2026-06-30
15 Verition Fund Management LLC $1.50M 0.63% 2026-06-30
16 Saba Capital Management, L.P. $823.15K 0.35% 2026-06-30
17 Walleye Capital LLC $598.66K 0.25% 2026-06-30
18 Two Sigma Investments, LP Custodian $355.45K 0.15% 2026-06-30
19 Capula Management Ltd $336.74K 0.14% 2026-06-30
20 Twin Tree Management, LP $187.08K 0.08% 2026-06-30
21 Qube Research & Technologies Ltd $18.71K <0.01% 2026-06-30

THC Insider Trading (Form 4)

Latest: 2026-09-16
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-16 J Robert Kerrey Director Sell (S) −12,010 $263.72 -$3.17M EDGAR
2026-09-14 Richard J Mark Director Sell (S) −10,000 $263.42 -$2.63M EDGAR
2026-09-03 Nadja West Director Sell (S) −1,152 $258.80 -$298.1K EDGAR
2026-09-01 Lisa Y Foo EVP, Chief Operating Officer Sell (S) −24,000 $266.32 -$6.39M EDGAR
2026-08-31 Cecil D Haney Director Gift (G) −150 — EDGAR
2026-08-26 Cecil D Haney Director Sell (S) −1,300 $278.03 -$361.4K EDGAR
2026-08-26 Saumya Sutaria CEO Sell (S) −100,000 $276.36 -$27.64M EDGAR
2026-08-10 Tammy Romo Director Sell (S) −7,422 $263.03 -$1.95M EDGAR
2026-08-07 Roy Blunt Director Sell (S) −600 $262.68 -$157.6K EDGAR
2026-08-07 Roy Blunt Director Sell (S) −600 $262.68 -$157.6K EDGAR
2026-07-31 Lisa Y Foo EVP, Chief Operating Officer Sell (S) −10,000 $258.03 -$2.58M EDGAR
2026-07-28 James L Bierman Director Sell (S) −5,000 $244.96 -$1.22M EDGAR
2026-07-28 Christopher S. Lynch Director Sell (S) −3,837 $243.44 -$934.1K EDGAR
2026-07-28 Paola M Arbour EVP, Chief Information Officer Sell (S) −10,878 $243.90 -$2.65M EDGAR
2026-05-29 J Robert Kerrey Director Sell (S) −5,638 $174.52 -$983.9K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

THC Insider Holdings

18 insiders · @ $270.06
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Saumya Sutaria CEO 533,993 $144.21M -$57.76M 33 2026-08-26
2 James L Bierman Director 31,604 $8.53M -$4.47M 15 2026-07-28
3 Tammy Romo Director 28,284 $7.64M -$7.94M 19 2026-08-10
4 Richard J Mark Director 25,121 $6.78M -$4.56M 15 2026-09-14
5 Nadja West Director 23,653 $6.39M -$1.47M 15 2026-09-03
6 Sun Park EVP & Chief Financial Officer 19,438 $5.25M $0 6 2026-03-03
7 Paola M Arbour EVP, Chief Information Officer 18,413 $4.97M -$13.46M 34 2026-07-28
8 Meghan Fitzgerald Director 17,087 $4.61M -$3.68M 15 2026-05-28
9 Cecil D Haney Director 12,403 $3.35M -$672.1K 12 2026-08-31
10 R. Scott Ramsey Principal Accounting Officer 11,131 $3.01M -$7.44M 36 2026-03-03
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

THC Board & Officers

As of SEC filings through Sep 16, 2026

Directors 12

Officers 7

Changes in the last 10 years (50)
May 1, 2026John Michael Grooms became Principal Accounting Officer
Mar 25, 2026The company announced the departure of R. Scott Ramsey as Principal Accounting Officer in an SEC filing
Feb 27, 2026Michael T. Maloney became EVP, Corporate Development
Nov 21, 2025The company announced the departure of Stephen H Rusckowski from the board in an SEC filing
Aug 22, 2025Lisa Y Foo listed as EVP, Chief Operating Officer (previously EVP, Commercial Ops) in SEC filings
Feb 13, 2025Saumya Sutaria listed as CEO (previously Chairman & CEO) in SEC filings
Feb 20, 2024Saumya Sutaria listed as Chairman & CEO (previously CEO) in SEC filings
Jan 2, 2024Daniel J Cancelmi reported in an SEC filing no longer being EVP & Chief Financial Officer
Jan 1, 2024Sun Park became EVP & Chief Financial Officer
Dec 11, 2023Vineeta Agarwala became a director
Aug 9, 2023Roy Blunt became a director
May 25, 2023Stephen H Rusckowski became a director
Mar 3, 2023Saumya Sutaria first listed as a director in an SEC filing
Mar 3, 2023Saumya Sutaria first listed as CEO in an SEC filing
Oct 4, 2022Ronald A Rittenmeyer reported in an SEC filing no longer being a director
Oct 4, 2022Ronald A Rittenmeyer reported in an SEC filing no longer being Executive Chairman
Mar 1, 2022Lisa Y Foo became EVP, Commercial Ops
Jan 7, 2022Saumya Sutaria reported in an SEC filing no longer being a director
Jan 7, 2022Saumya Sutaria reported in an SEC filing no longer being President & COO
Jan 4, 2022Audrey T. Andrews reported in an SEC filing no longer being EVP & General Counsel
Not reported recently (13)
  • Marie Quintana · Last reported as EVP, Marketing/Communications in an SEC filing dated Feb 28, 2022
  • Howard Hacker · Last reported as EVP, Chief Compliance Officer in an SEC filing dated Feb 28, 2022
  • Lloyd J. Austin III · Last reported as a director in an SEC filing dated Jun 2, 2020
  • Sandra R Karrmann · Last reported as EVP & Chief HR Officer in an SEC filing dated Mar 2, 2020
  • Edward A Kangas · Last reported as a director in an SEC filing dated Aug 30, 2019
  • Keith B Pitts · Last reported as Vice Chairman in an SEC filing dated Aug 27, 2019
  • Brenda J Gaines · Last reported as a director in an SEC filing dated May 7, 2019
  • Jason Eric Evans · Last reported as Pres. of Hospital Operations in an SEC filing dated May 1, 2018
  • Richard Pettingill · Last reported as a director in an SEC filing dated May 9, 2017
  • Karen M Garrison · Last reported as a director in an SEC filing dated May 9, 2017
  • Peter M Wilver · Last reported as a director in an SEC filing dated May 9, 2017
  • John P Byrnes · Last reported as a director in an SEC filing dated May 9, 2017
  • Trevor Fetter · Last reported as a director in an SEC filing dated Mar 14, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

THC Proposed Insider Sales (Form 144)

Latest: 2026-09-14
Last 30d: 0 filings  ·  Last 90d: 12 filings · $48.8M notice value · 9 unique filers

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Sutaria Saumya (2, $27.6M) · Foo Lisa Y (2, $9.0M) · KERREY J ROBERT (1, $3.2M) · Arbour Paola M (1, $2.7M) · MARK RICHARD J (1, $2.6M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-09-14 KERREY J ROBERT Director 12,010 $3.21M 2026-09-14 Fidelity Brokerage Services LLC — EDGAR
2026-09-10 MARK RICHARD J Director 10,000 $2.63M 2026-09-10 Fidelity Brokerage Services LLC — EDGAR
2026-08-31 Foo Lisa Y Officer 24,000 $6.39M 2026-08-31 Fidelity Brokerage Services LLC — EDGAR
2026-08-25 Sutaria Saumya Officer, Director 50,000 $13.70M 2026-08-25 Fidelity Brokerage Services LLC — EDGAR
2026-08-24 HANEY CECIL D Director 1,300 $361.4K 2026-08-24 Fidelity Brokerage Services LLC — EDGAR
2026-08-24 Sutaria Saumya Officer, Director 50,000 $13.94M 2026-08-24 Fidelity Brokerage Services LLC — EDGAR
2026-08-07 Romo Tammy Director 2,500 $652.1K 2026-08-07 Fidelity Brokerage Services LLC — EDGAR
2026-08-06 Romo Tammy Director 4,922 $1.30M 2026-08-06 Fidelity Brokerage Services LLC — EDGAR
2026-08-05 Blunt Roy Director 600 $157.6K 2026-08-05 Fidelity Brokerage Services LLC — EDGAR
2026-07-29 Foo Lisa Y Officer 10,000 $2.58M 2026-07-29 Fidelity Brokerage Services LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-29 0000070318-26-000028 EDGAR
2026-04-30 0000070318-26-000023 EDGAR
2026-04-10 0000070318-26-000019 EDGAR
2026-03-30 0000070318-26-000015 EDGAR
2026-02-11 0000070318-26-000007 EDGAR
2026-02-02 0000070318-26-000003 EDGAR
2025-11-24 0000070318-25-000050 EDGAR
2025-11-18 0001193125-25-286146 EDGAR
2025-11-05 0001193125-25-266885 EDGAR
2025-11-03 0000070318-25-000048 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-17 0000070318-26-000012 EDGAR
2025-02-18 0000070318-25-000009 EDGAR
2024-02-16 0000070318-24-000016 EDGAR
2023-02-21 0000070318-23-000010 EDGAR
2022-02-18 0000070318-22-000013 EDGAR
2021-02-19 0000070318-21-000008 EDGAR
2020-02-24 0000070318-20-000014 EDGAR
2019-02-25 0000070318-19-000017 EDGAR
2018-02-26 0000070318-18-000011 EDGAR
2017-02-27 0001558370-17-001079 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-04-30 0000070318-26-000026 EDGAR
2025-10-28 0000070318-25-000046 EDGAR
2025-07-30 0000070318-25-000039 EDGAR
2025-04-29 0000070318-25-000017 EDGAR
2024-10-29 0000070318-24-000052 EDGAR
2024-07-30 0000070318-24-000041 EDGAR
2024-04-30 0000070318-24-000032 EDGAR
2023-10-30 0000070318-23-000055 EDGAR
2023-07-31 0000070318-23-000041 EDGAR
2023-04-28 0000070318-23-000019 EDGAR
ETF Holders
204 ETFs hold THC
25 shown · $3.76B total exposure · 0.34% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJH iShares Core S&P Mid-Cap ETF iShares (BlackRock) 0.63% $776.5M $122.0B 2026-10-21
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.03% $653.3M — 2026-09-30
3 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.26% $463.1M — 2026-09-30
4 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.47% $301.4M — 2026-09-30
5 VXF Vanguard Extended Market ETF Vanguard 0.25% $231.7M — 2026-09-30
6 VFLO VictoryShares Free Cash Flow ETF Nport 2.37% $184.0M — 2026-06-30
7 MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust SPDR (State Street) 0.63% $162.8M $26.0B 2026-10-21
8 IJK iShares S&P Mid-Cap 400 Growth ETF iShares (BlackRock) 1.24% $130.4M $10.3B 2026-10-21
9 SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF SPDR (State Street) 0.63% $117.1M $18.5B 2026-10-21
10 COWZ Pacer US Cash Cows 100 ETF Nport 0.63% $114.1M — 2026-04-30
11 IWR iShares Russell Mid-Cap ETF iShares (BlackRock) 0.16% $90.0M $57.2B 2026-10-21
12 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.09% $83.7M — 2026-10-21
13 VHT Vanguard Health Care ETF Vanguard 0.31% $67.3M — 2026-09-30
14 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.06% $47.9M $84.8B 2026-10-21
15 SCHM Schwab U.S. Mid-Cap ETF Nport 0.29% $41.7M — 2026-05-31
16 DCOR Dimensional US Core Equity 1 ETF Dimensional 0.09% $38.7M — 2026-10-21
17 IHF iShares U.S. Healthcare Providers ETF iShares (BlackRock) 2.65% $36.7M $1.4B 2026-10-21
18 MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF SPDR (State Street) 1.24% $35.0M $2.8B 2026-10-21
19 IVOO Vanguard S&P Mid-Cap 400 ETF Vanguard 0.60% $34.4M — 2026-09-30
20 IWS iShares Russell Mid-Cap Value ETF iShares (BlackRock) 0.21% $32.7M $15.7B 2026-10-21
21 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.03% $28.3M $96.2B 2026-10-21
22 TMSL T. Rowe Price Small-Mid Cap ETF Nport 0.89% $24.1M — 2026-06-30
23 CGMM Capital Group U.S. Small and Mid Cap ETF Capitalgroup 0.64% $23.0M $3.6B 2026-10-21
24 FXH First Trust Health Care AlphaDEX® Fund First Trust 1.94% $22.1M $1.1B 2026-10-21
25 SMLF iShares U.S. Small-Cap Equity Factor ETF iShares (BlackRock) 0.52% $21.7M $4.2B 2026-10-21
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
10.42
TTM Diluted EPS
$25.92
TTM Revenue
$22.11B
TTM Net Income
$2.24B
TTM Op. Cash Flow
$4.01B
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$5.63B$826.00M$9.84$585.00M
Q1 '262026-03-31$5.78B$702.00M$8.01$1.64B
Q4 '252025-12-31$5.35B$371.00M$4.21$731.00M
Q3 '252025-09-30$5.35B$342.00M$3.86$1.06B
Q2 '252025-06-30$5.27B$288.00M$3.14$936.00M
Q1 '252025-03-31$5.22B$406.00M$4.27$815.00M
Q4 '242024-12-31$4.89B$318.00M$3.43$-331.00M
Q3 '242024-09-30$5.19B$472.00M$4.89$1.04B
Q2 '242024-06-30$5.11B$259.00M$2.64$747.00M
Q1 '242024-03-31$5.37B$2.15B$21.38$586.00M
Q4 '232023-12-31$5.38B$244.00M$2.30$824.00M
Q3 '232023-09-30$5.07B$101.00M$0.94$503.00M
Q2 2026 • period ending 2026-06-30 • filed 2026-07-29
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
10.42
P/B
3.61
P/S
1.07
EV/EBITDA
7.22
EV/Sales
1.57
ROE
34.2%
ROA
7.3%
Div Yield
0.00%
FCF Yield
16.94%
Debt/Equity
2.00
Current Ratio
—
Market Cap
$23.70B
as of 2026-10-23
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.83M
SI % of Float
2.29%
Days to Cover
2.12
Short Vol Ratio
38.9%
Free Float
79.75M
Float %
99.1%
Short interest 2026-09-30 • Short volume 2026-10-22 • Float 2026-08-14